essenti
zinc
human
establish
past
tremend
advanc
clinic
basic
scienc
zinc
metabol
human
observ
major
factor
contribut
zinc
defici
high
phytatecontain
cereal
protein
intak
develop
world
nearli
billion
subject
may
zinc
defici
condit
defici
zinc
observ
patient
malabsorpt
syndrom
liver
diseas
chronic
renal
diseas
sickl
cell
diseas
chronic
ill
major
clinic
problem
result
zinc
defici
human
includ
growth
retard
cellmedi
immun
dysfunct
cognit
impair
middl
east
zincdefici
dwarf
live
beyond
age
die
intercurr
infect
knew
enzym
requir
zinc
activ
know
enzym
transcript
factor
known
requir
zinc
activ
zinc
second
messeng
immun
cell
intracellular
free
zinc
cell
particip
signal
event
zinc
success
use
therapeut
modal
manag
acut
diarrhea
children
wilson
diseas
common
cold
prevent
blind
patient
agerel
dri
type
macular
degener
effect
decreas
incid
infect
elderli
zinc
modul
cellmedi
immun
also
antioxid
antiinflammatori
agent
essenti
zinc
growth
aspergillu
niger
observ
zinc
shown
essenti
growth
rat
although
essenti
zinc
growth
variou
anim
speci
report
consid
improb
zinc
defici
human
could
lead
signific
clinic
problem
train
clinic
scientist
univers
minnesota
minneapoli
mn
train
strang
set
circumst
brought
shiraz
iran
stori
zinc
began
iranian
physician
present
medic
center
grand
round
man
look
like
boy
sever
anem
genitalia
infantil
rough
dri
skin
mental
lethargi
hepatosplenomegali
geophagia
ate
bread
whole
wheat
flour
intak
anim
protein
consum
kg
clay
daili
sever
iron
defici
blood
loss
later
discov
syndrom
common
villag
shiraz
iran
iron
defici
alon
could
account
featur
observ
case
growth
retard
testicular
atrophi
seen
irondefici
experiment
anim
examin
period
tabl
suggest
defici
anoth
transit
element
perhap
zinc
may
also
present
may
account
growth
retard
hypogonad
hypothes
high
phosphat
content
diet
geophagia
may
decreas
avail
iron
zinc
result
defici
element
later
studi
egypt
document
conclus
zinc
defici
occur
human
zinc
supplement
result
cm
growth
genitalia
becam
normal
within
mo
zinc
supplement
nearli
decad
idea
zinc
defici
occur
human
remain
controversi
sever
report
howev
confirm
observ
nation
research
council
nation
academi
scienc
declar
zinc
essenti
element
human
establish
recommend
dietari
allow
rda
fda
made
mandatori
includ
zinc
total
parenter
nutrit
fluid
detail
circumst
lead
discoveri
human
zinc
defici
middl
east
present
anoth
paper
paper
nutrit
defici
zinc
present
throughout
develop
world
condit
defici
zinc
may
complic
mani
diseas
state
discuss
zinc
also
recogn
therapeut
role
manag
certain
diseas
also
present
chronolog
zincrel
observ
human
eggleton
china
demonstr
zinc
content
toenail
fingernail
skin
significantli
decreas
poor
chines
individu
beriberi
compar
healthi
subject
suggest
zinc
defici
may
factor
beriberi
anoth
public
eggleton
analyz
zinc
copper
differ
organ
tissu
chines
subject
sex
rang
age
die
miscellan
caus
show
element
present
tissu
examin
also
observ
wherea
zinc
concentr
organ
tissu
copper
concentr
liver
brain
kidney
hair
descend
order
cerebellum
contain
zinc
copper
cerebrum
use
dithizon
techniqu
lutz
analyz
zinc
variou
human
tissu
conclud
total
zinc
content
man
g
figur
remark
close
accept
today
absorpt
excret
zinc
first
investig
mccanc
widdowson
show
princip
rout
zinc
excret
fece
small
quantiti
zinc
excret
urin
vikbladh
analyz
serum
zinc
dithizon
techniqu
report
normal
level
mmoll
valu
similar
report
modern
techniqu
anoth
paper
vikbladh
report
serum
zinc
decreas
mani
chronic
diseas
includ
liver
diseas
valle
et
al
report
serum
zinc
concentr
decreas
patient
cirrhosi
liver
suggest
repres
condit
defici
zinc
due
hyperzincuria
first
case
zinc
defici
unit
state
report
caggiano
et
al
puerto
rican
subject
dwarfism
hypogonad
hypogammaglobulinemia
giardiasi
strongyloidosi
schistosomiasi
zinc
supplement
result
improv
growth
develop
hambidg
et
al
report
occurr
nutrit
zinc
defici
mexicanamerican
children
denver
co
respond
well
zinc
supplement
halst
et
al
publish
result
studi
involv
group
men
reject
iranian
armi
induct
center
malnutrit
two
women
old
also
includ
studi
uniqu
featur
subject
old
clinic
featur
similar
report
prasad
et
al
studi
mo
one
group
receiv
wellbalanc
diet
contain
adequ
anim
protein
plu
placebo
capsul
second
group
given
diet
plu
capsul
zinc
sulfat
contain
mg
element
zinc
third
group
receiv
diet
without
addit
supplement
mo
women
live
hous
dr
ronaghi
receiv
treatment
observ
program
zincsuppl
group
gain
consider
height
show
evid
earli
onset
sexual
function
defin
nocturn
emiss
male
menarch
femal
compar
receiv
wellbalanc
diet
sever
defici
zinc
acrodermat
enteropathica
barn
moynahan
report
girl
sever
acrodermat
enteropathica
treat
diiodohydroxyquinolon
lactosedefici
synthet
diet
show
satisfactori
respons
therapi
serum
zinc
concentr
significantli
decreas
therefor
administ
oral
zinc
sulfat
correct
defici
surprisingli
skin
lesion
gastrointestin
symptom
clear
zinc
supplement
zinc
inadvert
omit
child
regimen
child
suffer
relaps
howev
complet
respond
oral
zinc
therapi
author
attribut
zinc
defici
synthet
diet
patient
receiv
author
howev
soon
realiz
zinc
might
fundament
pathogenesi
rare
inherit
disord
clinic
improv
reflect
correct
zinc
statu
patient
origin
observ
quickli
confirm
patient
acrodermat
enteropathica
ae
throughout
world
underli
pathogenesi
zinc
defici
patient
due
malabsorpt
zinc
caus
mutat
intestin
zinc
transport
ae
lethal
autosom
recess
trait
usual
occur
infant
italian
armenian
iranian
lineag
abbrevi
use
ab
b
amyloid
protein
ad
alzheim
diseas
ae
acrodermat
enteropathica
app
amyloid
precursor
protein
crp
creactiv
protein
dc
dendrit
cell
hae
haec
human
vascular
endotheli
cell
human
promyelocyt
leukemia
cell
line
intercellular
adhes
molecul
ifn
interferon
insulinlik
growth
factor
mda
malondialdehyd
mnc
mononuclear
cell
nfkb
nuclear
factor
kb
oxldl
oxid
ldl
phap
phytohemagglutinin
p
pma
myrist
acet
ra
receptor
antagonist
rda
recommend
daili
allow
ro
reactiv
oxygen
speci
scd
sickl
cell
diseas
ra
solubl
receptor
antagonist
human
monocyt
leukemia
cell
line
tk
deoxythymidin
kinas
vascular
cell
adhes
molecul
diseas
develop
earli
month
life
soon
wean
breastfeed
dermatolog
manifest
sever
zinc
defici
patient
ae
includ
bullou
pustular
dermat
extrem
oral
anal
genit
area
around
orific
paronychia
alopecia
ophthalm
sign
includ
blephar
conjunct
photophobia
corneal
opac
neuropsychiatr
sign
includ
irrit
emot
instabl
tremor
occasion
cerebellar
ataxia
weight
loss
growth
retard
male
hypogonad
also
promin
clinic
featur
congenit
malform
fetus
infant
born
pregnant
women
ae
commonli
observ
ae
patient
increas
suscept
infect
thymic
hypoplasia
absenc
germin
center
lymph
node
plasmacytosi
spleen
seen
consist
cellmedi
function
abnorm
complet
correct
zinc
supplement
abnorm
chemotoxi
also
correct
zinc
therapi
ae
patient
clinic
cours
downhil
failur
thrive
complic
intercurr
bacteri
fungal
viral
opportunist
infect
gastrointestin
disturb
sever
includ
diarrhea
malabsorpt
steatorrhea
lactos
intoler
diseas
unrecogn
untreat
fatal
zinc
supplement
howev
result
complet
recoveri
ae
gene
local
region
chromosom
gene
encod
histidinerich
protein
refer
member
larg
famili
transmembran
protein
known
zinc
transport
patient
ae
mutat
gene
document
total
parenter
nutrit
kay
tasmanjon
report
occurr
sever
zinc
defici
subject
receiv
total
parenter
nutrit
prolong
period
without
zinc
okada
et
al
arakawa
et
al
report
similar
find
without
zinc
observ
document
sever
investig
inde
unit
state
zinc
routin
includ
total
parenter
fluid
subject
like
receiv
therapi
extend
period
patient
total
parenter
nutrit
diarrhea
may
lose
mgd
zinc
excess
loss
zinc
result
sever
defici
zinc
manifest
dermatolog
alopecia
neuropsychiatr
weight
loss
intercurr
infect
commonli
seen
neg
nitrogen
balanc
impair
carbohydr
util
zinc
defici
recogn
treat
condit
may
becom
fatal
zinc
defici
may
also
common
low
birth
weight
infant
fortifi
human
milk
preterm
formula
may
contain
zinc
physician
must
awar
problem
penicillamin
therapi
sever
defici
zinc
also
observ
patient
wilson
diseas
receiv
penicillamin
therapi
decopp
agent
treatment
may
induc
excess
zinc
loss
caus
sever
defici
zinc
summari
manifest
sever
zinc
defici
human
includ
bullou
pustular
dermat
alopecia
diarrhea
emot
disord
weight
loss
intercurr
infect
due
cellmedi
immun
dysfunct
hypogonad
male
neurosensori
disord
problem
heal
ulcer
sever
defici
zinc
untreat
may
becom
fatal
manifest
moder
defici
zinc
includ
growth
retard
male
hypogonad
adolesc
rough
skin
poor
appetit
mental
lethargi
delay
wound
heal
cellmedi
immun
dysfunct
abnorm
neurosensori
chang
manifest
report
subject
nutrit
defici
zinc
observ
origin
iran
egypt
mani
subject
condit
defici
zinc
appar
nutrit
defici
zinc
human
fairli
preval
throughout
world
particularli
area
cereal
protein
primari
local
diet
turkey
geophagia
also
common
problem
major
adolesc
villag
turkey
geophagia
exhibit
iron
zinc
defici
cavdar
et
al
observ
decreas
zinc
level
almost
low
socioeconom
statu
pregnant
women
turkey
diet
consist
mainli
cereal
matern
zinc
defici
associ
sever
congenit
malform
central
nervou
system
fetus
matern
morbid
increas
zinc
growth
growth
first
limit
effect
zinc
defici
experiment
anim
zinc
defici
decreas
circul
insulinlik
growth
factor
concentr
independ
total
energi
intak
human
zinc
defici
decreas
circul
concentr
receptor
possess
tyrosin
kinas
activ
activ
receptor
igf
cascad
phosphoryl
occur
within
cell
lead
regul
cell
cycl
cell
divis
tyrosin
phosphoryl
receptor
essenti
activ
hypothes
zinc
shown
inhibit
variou
protein
tyrosin
phosphatas
phosphoryl
tyrosin
kinas
receptor
zinc
perhap
import
critic
step
zinc
action
human
growth
activ
lead
stimul
thymidin
uptak
cell
earlier
studi
show
zincdefici
rat
activ
deoxythymidin
kinas
tk
enzym
requir
convers
deoxythymidin
deoxythymidin
precursor
thymidin
triphosph
consider
decreas
implant
spong
connect
tissu
reduc
activ
tk
decreas
dna
protein
collagen
synthesi
rat
thu
appear
zinc
multipl
role
growth
requir
gener
phosphoryl
receptor
upregul
activ
tk
involv
cell
divis
growth
although
clinic
biochem
diagnost
aspect
sever
moder
level
zinc
defici
human
well
defin
recognit
mild
defici
zinc
remain
difficult
therefor
develop
experiment
model
zinc
defici
human
defin
mild
zinc
defici
group
human
volunt
induc
mild
state
zinc
defici
dietari
mean
adult
male
volunt
hospit
clinic
research
center
univers
michigan
medic
school
hospit
ann
arbor
mi
semipurifi
diet
mgd
zinc
use
induc
zinc
defici
volunt
given
hospit
diet
contain
anim
protein
daili
wk
diet
averag
mgd
zinc
consist
rda
receiv
mgd
zinc
consum
soy
proteinbas
experiment
diet
regimen
continu
wk
volunt
receiv
cooki
contain
mg
zinc
supplement
supplement
continu
wk
throughout
studi
level
nutrient
includ
protein
amino
acid
vitamin
miner
micro
macro
element
kept
constant
meet
rda
except
zinc
techniqu
abl
induc
specif
mild
defici
zinc
human
volunt
result
mild
defici
zinc
observ
decreas
serum
testosteron
level
oligospermia
decreas
natur
killer
cell
lytic
activ
decreas
activ
helper
cell
decreas
serum
thymulin
activ
hyperammonemia
hypogeusia
decreas
dark
adapt
decreas
lean
bodi
mass
studi
clearli
establish
even
mild
defici
zinc
human
affect
clinic
biochem
immunolog
function
advers
zinc
immun
cell
zinc
second
messeng
immun
cell
intracellular
statu
directli
alter
extracellular
stimulu
intracellular
zinc
particip
signal
event
hirano
et
al
show
decreas
intracellular
free
zinc
critic
lpsmediat
tcell
activ
dendrit
cell
dc
lp
bind
tolllik
receptor
dc
initi
trif
domain
contain
adapterinduc
interferon
ifn
b
mediat
signal
trifmedi
signal
increas
znt
solut
carrier
mrna
decreas
mrna
thu
result
decreas
intracellular
free
zinc
dc
reduct
intracellular
free
zinc
increas
surfac
express
major
histocompat
complex
class
ii
molecul
import
activ
cell
zinc
affect
activ
monocytesmacrophag
sever
way
zinc
involv
monocytemacrophag
develop
regul
function
phagocytosi
proinflammatori
cytokin
product
lp
stimul
zincsuffici
monocyt
result
downregul
inflammatori
cytokin
tnfa
zinc
inhibit
membran
phosphodiesteras
lead
elev
level
second
messeng
guanosin
cyclic
monophosph
follow
subsequ
suppress
nuclear
factor
kb
nfkb
depend
mrna
tnfa
inflammatori
cytokin
addit
zinc
induc
inhibit
nfkb
signal
via
tnf
receptorassoci
factor
pathway
result
downregul
mrna
inflammatori
cytokin
base
propos
zinc
import
antiinflammatori
agent
zinc
defici
affect
helper
subset
cell
function
advers
human
serum
thymulin
activ
gener
helper
subset
cell
cytokin
ifng
affect
within
wk
institut
zincrestrict
diet
mgd
human
volunt
wherea
plasma
zinc
decreas
wk
institut
experiment
diet
suggest
helper
subset
cell
sensit
zinc
restrict
helper
subset
cell
cytokin
affect
result
institut
zincdefici
diet
human
human
malign
lymphoblastoid
cell
line
phenotyp
cell
human
malign
lymphoblastoid
cell
line
phenotyp
show
zincsuffici
cell
mrna
level
ifng
receptor
b
tbet
transcript
factor
involv
tcell
differenti
myrist
acet
pma
phytohemagglutininp
pha
stimul
cell
increas
compar
zincdefici
cell
although
intracellular
free
noncoval
bound
zinc
zinc
increas
slightli
pmaphastimul
cell
concanavalin
astimul
cell
zincsuffici
medium
increas
sustain
level
intracellular
free
zinc
compar
zincdefici
cell
conclud
stimul
cell
concanvalin
via
tcell
receptor
releas
intracellular
free
zinc
function
signal
transduct
molecul
gener
ifng
tbet
receptor
b
mrna
requir
helper
subset
cell
differenti
condit
defici
zinc
gi
disord
moder
level
zinc
defici
observ
mani
gastrointestin
disord
includ
malabsorpt
syndrom
crohn
diseas
region
ileiti
steatorrhea
macmahon
et
al
first
report
zinc
defici
patient
steatorrhea
zinc
defici
patient
malabsorpt
syndrom
well
recogn
physician
awar
problem
liver
diseas
low
serum
hepat
zinc
paradox
hyperzincuria
report
patient
cirrhosi
liver
mani
year
ago
patient
cirrhosi
liver
night
blind
respond
vitamin
supplement
howev
respond
zinc
administr
elev
blood
ammonia
level
known
factor
develop
hepat
coma
known
zincdefici
rat
defect
metabol
sulfurcontain
amino
acid
zinc
defici
also
affect
urea
synthesi
thu
abnorm
relat
metabol
amino
acid
ammonia
may
act
concert
produc
hepat
coma
report
earlier
dietari
zinc
restrict
may
lead
hyperammonemia
rabbani
prasad
observ
decreas
hepat
ornithin
transcarbamoylas
activ
increas
plasma
ammonia
level
zincdefici
rat
addit
increas
activ
purin
nucleotid
enzym
adenosin
monophosph
deaminas
result
zinc
defici
also
observ
may
also
contribut
increas
ammonia
level
zinc
therapi
report
benefici
subject
hepat
encephalopathi
studi
need
import
area
like
clinic
featur
cirrhosi
liver
loss
bodi
hair
testicular
hypofunct
poor
appetit
mental
lethargi
difficulti
heal
abnorm
cellmedi
immun
night
blind
may
inde
relat
secondari
zincdefici
state
induc
hyperzincuria
renal
diseas
mahajan
et
al
first
document
patient
chronic
renal
failur
show
decreas
concentr
zinc
plasma
leukocyt
hair
increas
plasma
ammonia
level
increas
activ
plasma
ribonucleas
urem
hypogeusia
improv
zinc
supplement
impot
common
urem
male
improv
hemodialysi
doubleblind
clinic
trial
zinc
supplement
show
zinc
defici
revers
caus
sexual
dysfunct
uremia
zinc
defici
sickl
cell
diseas
studi
document
occurr
zinc
defici
adult
sickl
cell
diseas
scd
patient
growth
retard
hypogonad
male
hyperammonemia
abnorm
dark
adapt
cellmedi
immun
dysfunct
scd
patient
relat
defici
zinc
biochem
evid
zinc
defici
scd
patient
decreas
level
zinc
plasma
erythrocyt
hair
hyperzincuria
decreas
activ
certain
zincdepend
enzym
carbon
anhydras
erythrocyt
alkalin
phosphatas
neutrophil
deoxythymidin
kinas
activ
newli
synthes
skin
connect
tissu
collagen
hyperammonemia
inasmuch
zinc
known
inhibitor
rna
increas
activ
enzym
plasma
consid
also
evid
zinc
defici
zinc
supplement
scd
patient
result
signific
improv
secondari
sexual
characterist
normal
plasma
ammonia
level
correct
dark
adapt
abnorm
zinc
supplement
also
increas
zinc
level
plasma
erythrocyt
neutrophil
expect
respons
zinc
supplement
enzym
activ
also
observ
increas
longitudin
growth
bodi
weight
scd
patient
observ
zinc
supplement
also
correct
impair
delayedtyp
hypersensit
reaction
decreas
natur
killer
cell
lytic
activ
scd
patient
placebocontrol
zinc
supplement
trial
mg
zinc
zinc
acet
time
day
scd
patient
show
zincsuppl
subject
decreas
incid
infect
increas
hemoglobin
hematocrit
level
increas
plasma
zinc
antioxid
power
compar
placebo
group
plasma
nitrit
nitrat
lipid
peroxid
product
dna
oxid
product
solubl
vascular
cell
adhes
molecul
decreas
zincsuppl
group
compar
placebo
group
zincsuppl
subject
show
signific
decreas
lpsinduc
tnfa
mrna
tnfinduc
nfkb
dna
bind
mononuclear
cell
mnc
compar
placebo
group
zinc
supplement
also
increas
rel
level
receptor
mrna
phastimul
mnc
therapeut
impact
zinc
zinc
infecti
diseas
acut
diarrhea
children
supplement
zinc
shown
prevent
treat
diarrhea
children
younger
age
decreas
diarrhea
morbid
mortal
zinc
defici
also
correl
risk
respiratori
tract
infect
benefit
supplement
appear
limit
sever
episod
popul
high
incid
zinc
defici
diarrhea
caus
breakdown
absorpt
mucosa
result
poor
absorpt
nutrient
includ
zinc
studi
conduct
earlier
link
diarrheal
ill
loss
endogen
zinc
children
low
plasma
zinc
observ
suscept
diarrhea
pathogen
propag
cycl
defici
infect
extens
evid
support
efficaci
zinc
supplement
prevent
childhood
diarrhea
issu
global
recommend
daili
supplement
mg
zinc
children
mo
age
older
mg
zinc
infant
younger
mo
diarrheal
onset
metaanalysi
routin
supplement
long
mo
studi
provid
time
rda
element
zinc
time
per
week
found
reduct
diarrheal
incid
decreas
diarrhea
preval
reduct
persist
diarrhea
episod
among
supplement
children
compar
children
receiv
placebo
metaanalysi
random
control
trial
provid
shortcours
zinc
supplement
time
daili
rda
wk
onset
episod
acut
persist
diarrhea
report
pool
analysi
show
decreas
diarrhea
incid
decreas
diarrhea
preval
observ
period
sever
infect
zinc
children
seriou
bacteri
infect
major
caus
death
earli
infanc
develop
countri
studi
effect
zinc
adjunct
antibiot
infant
probabl
seriou
bacteri
infect
assess
random
doubleblind
placebocontrol
zinc
supplement
trial
infant
age
probabl
seriou
bacteri
infect
hospit
new
delhi
india
conduct
patient
stratifi
accord
whether
underweight
diarrhea
enrol
receiv
either
mg
zinc
placebo
oral
everi
day
addit
standard
antibiot
treatment
primari
outcom
treatment
failur
defin
need
chang
antibiot
within
random
need
intens
care
manag
death
time
within
significantli
fewer
treatment
failur
occur
zinc
group
compar
placebo
group
ten
infant
receiv
zinc
die
compar
receiv
placebo
zinc
treatment
common
cold
common
cold
one
frequent
occur
diseas
world
virus
caus
common
cold
includ
rhinoviru
coronaviru
adenoviru
respiratori
syncyti
viru
parainfluenza
viru
annual
adult
unit
state
may
develop
common
cold
time
year
children
may
develop
cold
time
year
morbid
subsequ
financi
loss
result
absente
work
substanti
previous
prescrib
treatment
provid
consist
relief
symptom
ebi
et
al
first
show
doubleblind
placebocontrol
trial
zinc
glucon
lozeng
administ
everi
h
effect
decreas
sever
durat
common
cold
test
efficaci
zinc
acet
lozeng
common
cold
volunt
recruit
within
h
symptom
common
cold
develop
conduct
random
doubleblind
placebocontrol
trial
particip
took
lozeng
contain
mg
zinc
acet
placebo
everi
h
awak
soon
common
cold
symptom
develop
subject
symptom
score
sore
throat
nasal
discharg
nasal
congest
sneez
cough
scratchi
throat
hoars
muscl
ach
fever
headach
record
daili
plasma
zinc
proinflammatori
cytokin
assay
day
particip
well
twentyf
zinc
group
placebo
group
complet
studi
compar
placebo
group
zinc
group
shorter
overal
durat
cold
symptom
vs
p
cough
vs
p
nasal
discharg
vs
p
decreas
total
sever
score
symptom
p
anoth
studi
recruit
ambulatori
volunt
within
h
common
cold
symptom
develop
random
doubleblind
placebocontrol
trial
zinc
particip
took
lozeng
contain
mg
zinc
zinc
acet
placebo
everi
h
awak
subject
score
clinic
symptom
record
daili
plasma
zinc
solubl
receptor
antagonist
ra
solubl
tnf
receptor
solubl
assay
day
compar
placebo
group
zinc
group
shorter
mean
overal
durat
cold
vs
p
cough
vs
p
nasal
discharg
vs
p
blind
subject
adequ
advers
effect
compar
group
symptom
sever
score
significantli
decreas
zinc
group
p
mean
chang
zinc
placebo
group
vs
therapi
show
signific
differ
solubl
p
solubl
level
p
decreas
zinc
group
mean
chang
zinc
placebo
group
vs
therapi
show
signific
differ
p
result
suggest
common
cold
virus
increas
oxid
stress
activ
macrophag
monocyt
result
increas
product
inflammatori
cytokin
antiinflammatori
product
solubl
thu
decreas
solubl
zinc
group
suggest
zinc
decreas
activ
monocyt
macrophag
decreas
oxid
stress
previous
show
zinc
function
antioxid
human
rhinoviru
type
dock
surfac
somat
cell
thu
zinc
may
act
antivir
agent
reduc
level
previous
show
zinc
function
downregul
nfkb
activ
involv
gene
express
adhes
molecul
conclud
zinc
acet
lozeng
given
within
h
onset
common
cold
proper
dose
effect
decreas
durat
sever
common
cold
propos
benefici
effect
seen
zinc
group
due
antioxid
antiinflammatori
effect
zinc
also
suggest
decreas
plasma
level
due
zinc
therapi
may
decreas
dock
cold
virus
surfac
somat
cell
metaanalysi
select
random
doubleblind
placebocontrol
trial
use
zinc
least
consecut
day
treat
least
mo
prevent
common
cold
includ
analysi
thirteen
therapeut
trial
particip
prevent
trial
particip
includ
analysi
studi
report
durat
sever
cold
symptom
suggest
zinc
significantli
reduc
overal
durat
sever
common
cold
symptom
therapi
start
within
h
onset
cold
zinc
supplement
prevent
common
cold
show
incid
common
cold
school
absente
use
antibiot
decreas
anoth
metaanalysi
placebocontrol
studi
examin
therapeut
effect
zinc
lozeng
common
cold
symptom
five
trial
use
total
daili
zinc
dose
mg
uniformli
found
effect
three
trial
use
zinc
acet
daili
dose
mg
pool
result
show
reduct
durat
cold
five
trial
use
zinc
salt
rather
acet
daili
dose
mg
pool
result
show
reduct
durat
common
cold
anoth
report
investig
includ
random
control
trial
analyz
effect
zinc
common
cold
although
author
observ
increas
heterogen
due
age
zinc
dose
chemic
formul
conclud
zinc
may
shorten
durat
common
cold
optim
therapeut
effect
zinc
lozeng
common
cold
one
must
pay
attent
sever
issu
first
zinc
therapi
must
begin
within
h
onset
cold
symptom
second
total
daili
dose
element
zinc
mg
third
chemic
formul
optim
zinc
ioniz
oral
caviti
ph
zinc
acet
zinc
glucon
good
salt
use
howev
citric
acid
glycin
tartar
binder
use
zinc
prevent
ioniz
thu
critic
solut
chemistri
prepar
proper
physician
health
practition
must
realiz
one
treat
common
cold
symptom
swallow
zinc
tablet
zinc
syrup
zinc
lozeng
zinc
lozeng
must
use
oral
allow
dissolv
slowli
mouth
allow
ionic
zinc
releas
absorb
transport
viral
infect
nose
zinc
therapi
wilson
diseas
wilson
diseas
inherit
autosom
disord
copper
accumul
excret
liver
copper
bile
decreas
lead
failur
proper
copper
excret
stool
accumul
copper
liver
eventu
liver
also
brain
organ
damag
due
excess
copper
accumul
patient
typic
present
liver
diseas
neurolog
diseas
movement
disord
psychiatr
disturb
second
fourth
decad
life
mani
case
diagnosi
either
miss
delay
gene
wilson
diseas
identifi
genet
mutat
lead
defect
product
protein
call
membranebound
copperbind
atp
respons
key
step
biliari
excret
copper
diseas
recess
thu
copi
gene
mutat
caus
failur
biliari
excret
copper
produc
diseas
gene
wilson
diseas
code
membranebound
copperbind
atptyp
protein
probabl
act
copper
pump
either
plasma
membran
intracellular
membran
larg
number
mutat
gene
caus
wilson
diseas
identifi
complic
develop
easi
dna
test
diagnosi
diseas
import
establish
earli
diagnosi
wilson
diseas
effect
therapeut
measur
may
prevent
accumul
copper
seriou
damag
organ
liver
brain
nineti
percent
wilson
diseas
patient
low
level
ceruloplasmin
ceruloplasminbound
copper
nonceruloplasminbound
copper
elev
plasma
measur
urinari
copper
good
diagnost
test
consist
elev
patient
urinari
copper
howev
may
elev
patient
obstruct
liver
diseas
also
wilson
diseas
slitlamp
examin
corneal
copper
deposit
kayserfleisch
ring
use
noninvas
diagnost
test
wilson
diseas
posit
hepat
case
invari
present
neurolog
case
wilson
diseas
initi
treatment
object
decreas
copper
level
otherwis
affect
copper
new
copper
toxic
avoid
also
desir
prevent
copper
shift
one
pool
decopp
done
initi
copper
control
treatment
may
take
mo
sever
year
ago
use
mg
element
zinc
divid
dose
treatment
sickl
cell
diseas
scd
patient
observ
zinc
effect
antisickl
drug
observ
level
zinc
therapi
treatment
result
induc
copper
defici
patient
led
brewer
et
al
develop
zinc
effect
anticopp
drug
wilson
diseas
zinc
compet
copper
similar
bind
site
oral
zinc
decreas
uptak
copper
effici
zinc
may
also
act
induct
intestin
cell
metallothionein
metallothionein
induc
high
affin
bind
copper
prevent
seros
transfer
copper
blood
intestin
cell
turnov
rapidli
take
complex
copper
stool
final
excret
zinc
block
food
copper
also
copper
endogen
excret
via
salivari
gastric
gastrointestin
juic
thu
zinc
effect
produc
chronic
neg
copper
balanc
fifti
milligram
element
zinc
acet
given
oral
time
day
manag
wilson
diseas
patient
zinc
given
fast
postabsorpt
state
side
effect
subject
may
gastric
discomfort
usual
observ
first
morn
dose
avoid
zinc
administ
breakfast
lunch
dinner
go
bed
mainten
therapi
zinc
drug
choic
rel
speak
zinc
toxic
nonteratogen
thu
given
subject
age
even
pregnant
women
zinc
approv
fda
treatment
wilson
diseas
patient
agerel
macular
degener
amd
affect
nearli
individu
older
age
latestag
diseas
account
nearli
legal
blind
europ
north
america
newsom
et
al
demonstr
concentr
zinc
reduc
human
eye
sign
amd
suggest
zinc
defici
may
lead
oxid
stress
retin
damag
agerel
eye
diseas
studi
group
support
nation
eye
institutenih
conduct
doubleblind
clinic
trial
patient
drytyp
amd
total
particip
enrol
age
rang
averag
followup
period
particip
randomli
assign
receiv
daili
oral
one
follow
antioxid
vitamin
c
mg
vitamin
e
iu
bcaroten
mg
zinc
mg
zinc
oxid
copper
mg
copper
oxid
prevent
copper
defici
induc
zinc
antioxid
plu
zinc
placebo
group
take
antioxid
plu
zinc
supplement
risk
advanc
amd
develop
reduc
vision
loss
group
take
zinc
alon
risk
advanc
amd
develop
reduc
vision
loss
group
take
vitamin
alon
risk
advanc
amd
develop
decreas
vision
loss
decreas
signific
side
effect
note
subject
receiv
high
level
therapeut
zinc
studi
confirm
antioxid
effect
zinc
human
interestingli
zincsuppl
group
show
increas
longev
risk
mortal
reduc
agerel
eye
diseas
studi
group
studi
subject
age
receiv
therapeut
zinc
daili
present
ophthalmologist
throughout
world
use
zinc
vitamin
supplement
treatment
dri
type
amd
daili
intak
zinc
elderli
subject
western
world
includ
unit
state
mg
wherea
rda
mg
elderli
frequent
eat
usual
meal
day
skip
either
breakfast
lunch
mani
live
alon
cook
proper
meal
studi
detroit
area
show
welloff
ambulatori
elderli
subject
may
defici
zinc
base
plasma
zinc
level
zinc
defici
suscept
infect
due
cellmedi
immun
dysfunct
report
occur
elderli
third
nhane
also
found
elderli
person
older
greatest
risk
inadequ
zinc
intak
oxid
stress
increas
inflammatori
cytokin
recogn
import
contribut
factor
sever
chronic
diseas
attribut
age
atherosclerosi
relat
cardiovascular
disord
mutagenesi
cancer
neurodegen
disord
type
diabet
mellitu
alzheim
diseas
ad
togeth
h
oh
radic
reactiv
oxygen
speci
ro
excess
gener
ro
caus
oxid
stress
inflammatori
cytokin
tnfa
gener
activ
monocyt
also
known
gener
greater
level
ro
chronic
inflammatori
process
implic
high
cardiovascular
mortal
elderli
subject
previou
studi
show
zinc
supplement
individu
age
decreas
oxid
stress
marker
malondialdehyd
mda
hae
plasma
downregul
ex
vivo
induct
tnfa
mrna
mnc
provid
protect
tnfainduc
nfkb
activ
isol
mnc
also
show
previous
human
promyelocyt
leukemia
cell
line
differenti
monocyt
macrophag
phenotyp
respons
pma
zinc
upregul
express
bind
transactiv
factor
dna
result
inhibit
nfkb
activ
inasmuch
zinc
defici
suscept
infect
due
cellmedi
immun
dysfunct
observ
elderli
conduct
random
placebocontrol
trial
zinc
supplement
healthi
elderli
subject
sex
ethnic
group
st
patrick
senior
citizen
center
detroit
mi
one
subject
zinc
group
drop
second
day
thu
complet
data
subject
zinc
group
placebo
group
exclus
criteria
follow
life
expect
mo
progress
neoplast
diseas
sever
cardiac
dysfunct
signific
kidney
diseas
signific
liver
diseas
subject
compet
mental
zinc
supplement
consist
mg
element
zinc
glucon
daili
mo
comparison
baselin
data
younger
subject
age
n
elderli
subject
show
plasma
zinc
lower
percentag
cell
produc
tnfa
gener
cytokin
significantli
higher
elderli
subject
vcam
vascular
endotheli
cell
adhes
molecul
eselectin
plasma
also
significantli
higher
elderli
gener
helper
subset
cell
known
regul
neg
gener
helper
subset
cell
significantli
higher
elderli
similar
observ
respect
gener
cell
elderli
also
report
cakman
et
al
oxid
stress
marker
also
significantli
higher
elderli
compar
younger
adult
mean
incid
infect
per
subject
mo
significantli
lower
p
zincsuppl
group
placebo
group
effect
size
plasma
zinc
increas
ex
vivo
gener
tnfa
decreas
significantli
zinc
group
compar
placebo
group
oxid
stress
biomark
plasma
also
decreas
significantli
zinc
group
compar
placebo
group
mnc
isol
zincdefici
elderli
subject
zinc
supplement
increas
ex
vivo
phainduc
mrna
express
plasma
zinc
concentr
compar
zincdefici
subject
receiv
placebo
thu
studi
show
zinc
supplement
mgd
element
zinc
elderli
subject
decreas
incid
infect
nearli
supplement
also
observ
oxid
stress
marker
gener
inflammatori
cytokin
increas
supplement
decreas
significantli
highli
signific
effect
zinc
supplement
elderli
may
impli
zinc
may
also
prove
excel
agent
prevent
chronic
diseas
oxid
stress
increas
gener
inflammatori
cytokin
implic
initi
progress
mani
chronic
diseas
includ
atherosclerosi
diabet
mellitu
type
neurodegen
disord
ad
malign
inasmuch
zinc
requir
cellmedi
immun
also
effect
antioxid
antiinflammatori
agent
hypothes
zinc
prove
effect
therapeut
agent
manag
disord
section
present
rational
use
therapeut
zinc
manag
atherosclerosi
diabet
mellitu
type
ad
present
atherosclerosi
slowli
progress
chronic
inflammatori
diseas
character
focal
arteri
lesion
ultim
block
blood
vessel
lead
angina
myocardi
infarct
cerebrovascular
ischemia
stroke
even
death
inflamm
oxid
stress
andor
endotheli
dysfunct
caus
known
risk
factor
age
sex
smoke
hypertens
diabet
obes
involv
develop
progress
atherosclerosi
previou
studi
show
zinc
defici
increas
gener
inflammatori
cytokin
increas
oxid
stress
induc
endotheli
cell
dysfunct
studi
also
show
zinc
defici
may
affect
nearli
welloff
healthi
ambulatori
elderli
subject
detroit
area
subject
decreas
plasma
zinc
increas
plasma
lipid
peroxid
product
endotheli
cell
adhes
molecul
compar
healthi
zincsuffici
younger
adult
observ
random
placebocontrol
zinc
supplement
trial
elderli
subject
examin
effect
supplement
plasma
creactiv
protein
crp
macrophag
chemoattract
protein
vcam
oxid
stress
marker
addit
examin
effect
zinc
supplement
ppara
nfkb
activ
haec
monocyt
cell
line
human
monocyt
leukemia
cell
line
zincsuppl
group
receiv
mgd
zinc
glucon
mo
level
zinc
supplement
elderli
observ
decreas
copper
statu
plasma
zinc
increas
zincsuppl
group
chang
observ
placebo
group
observ
signific
decreas
lipid
peroxid
product
signific
increas
antioxid
power
repres
ascorb
equival
unit
uml
zincsuppl
group
compar
placebo
group
plasma
highsensit
crp
zincsuppl
group
decreas
significantli
compar
placebo
group
plasma
macrophag
chemoattract
protein
secretori
phospholipas
solubl
solubl
eselectin
decreas
zinc
supplement
mean
chang
group
statist
signific
plasma
zinc
concentr
elderli
subject
invers
correl
chang
plasma
concentr
highsensit
crp
macrophag
chemoattract
protein
mdaha
mo
supplement
zinc
decreas
gener
tnfa
mdaha
haec
incub
oxid
ldl
oxldl
h
compar
zincdefici
cell
zinc
increas
ppara
protein
oxldlstimul
cell
haec
compar
zincdefici
cell
effect
zinc
nfkb
activ
cell
haec
shown
figur
signific
differ
nfkb
activ
either
nfkbdriven
luciferas
report
gene
assay
electrophoret
mobil
shift
assay
nonstimul
cell
haec
incub
zincdefici
zincsuffici
media
howev
h
oxldl
stimul
zincsuffici
cell
haec
show
signific
decreas
nfkb
activ
compar
zincdefici
cell
high
plasma
crp
concentr
risk
factor
independ
risk
factor
total
cholesterol
ldl
age
smoke
bmi
diabet
hypertens
crp
wide
use
marker
atherosclerosi
clinic
cours
complic
prognosi
prospect
studi
healthi
men
women
increas
baselin
level
crp
greater
risk
coronari
arteri
diseas
studi
show
zinc
supplement
mg
element
zinc
glucon
daili
effect
lower
plasma
crp
concentr
first
document
show
zinc
effect
downregul
plasma
crp
level
elderli
increas
product
ro
activ
redoxdepend
signal
cascad
involv
atherosclerosi
ro
initi
nfkbmediat
transcript
activ
inflammatori
gene
therebi
potenti
act
independ
trigger
atherosclerosi
zinc
defici
increas
oxid
stress
zinc
supplement
decreas
oxid
stress
cell
cultur
model
human
confirm
studi
zinc
supplement
decreas
oxid
stress
elderli
subject
human
vascular
endotheli
monocyt
cell
thu
decreas
oxid
stress
zinc
may
decreas
ldl
oxid
exhibit
atheroprotect
effect
nfkb
one
major
immun
respons
transcript
factor
involv
initi
develop
atherosclerosi
zinc
play
import
role
nfkb
activ
howev
regul
nfkb
activ
zinc
cell
specif
zinc
requir
nfkb
dna
bind
purifi
recombin
nfkb
protein
helper
cell
line
addit
studi
also
show
zinc
decreas
lp
ro
tnfainduc
nfkb
activ
endotheli
cell
cancer
cell
report
previous
compar
control
healthi
volunt
supplement
zinc
mgd
signific
decreas
tnfa
mrna
tnfa
induc
nfkb
dna
bind
isol
peripher
blood
mononuclear
cell
zinc
upregul
express
cell
studi
observ
zinc
decreas
oxldlinduc
gener
tnfa
oxid
stress
marker
activ
nfkb
increas
protein
human
monocyt
vascular
endotheli
cell
propos
zinc
inhibit
nfkb
activ
induc
transactiv
factor
play
role
reduc
tnfainduc
nfkb
activ
inhibit
nfkb
signal
via
tnf
receptorassoci
factor
pathway
endotheli
cell
concept
mechan
zinc
may
benefici
regul
variou
pathway
involv
develop
atherosclerosi
present
figur
inflamm
gener
ro
result
oxldl
oxldl
activ
nfkb
induc
kinasenfkb
signal
pathway
upregul
downstream
target
gene
inflammatori
cytokin
crp
adhes
molecul
induc
nitric
oxid
synthas
cyclooxygenas
fibrinogen
tissu
factor
cytokin
molecul
attract
blood
cell
platelet
lead
coagul
initi
develop
atherosclerosi
show
zinc
supplement
increas
plasma
concentr
antioxid
power
decreas
plasma
concentr
figur
effect
zinc
peroxisom
proliferatoractiv
receptor
ppara
human
monocyt
leukemia
cell
line
human
aortic
endotheli
cell
haec
b
c
oxid
ldl
oxldl
stimul
cell
incub
either
zincdefici
mmoll
zincsuffici
zn
mmoll
medium
haec
follow
h
stimul
mg
oxldlml
ppara
protein
measur
western
blot
analysi
p
compar
zn
valu
sd
n
gadph
glyceraldehyd
dehydrogenas
reproduc
permiss
inflammatori
cytokin
lipid
peroxid
biomark
elderli
subject
view
result
recommend
control
prospect
trial
zinc
supplement
elderli
subject
conduct
establish
atheroprotect
effect
zinc
immens
impact
manag
patient
coronari
arteri
diseas
patient
stroke
diabet
mellitu
one
common
chronic
diseas
accord
estim
nearli
million
individu
affect
disord
diabet
one
major
caus
blind
increas
risk
cardiovascular
disord
endstag
renal
diseas
nontraumat
limb
amput
insulin
produc
b
cell
pancrea
essenti
glucos
clearanc
blood
muscl
fat
liver
cell
hallmark
diabet
loss
control
glycemia
due
lack
insulin
may
rel
absolut
depend
type
diabet
type
diabet
mellitu
alon
account
case
diabet
caus
autoimmun
destruct
pancreat
b
cell
result
virtual
product
insulin
without
insulin
carbohydr
use
energi
therefor
fat
becom
main
intracellular
sourc
energi
result
gener
keton
bodi
lead
ketoacidosi
exogen
insulin
administr
main
treatment
situat
type
diabet
mellitu
account
case
diabet
due
insulin
resist
problem
insulin
product
initi
b
cell
eventu
howev
islet
b
cell
function
also
declin
lead
overt
diabet
patient
ultim
also
requir
exogen
insulin
treatment
zinc
crucial
pancrea
regul
blood
glucos
insulin
store
crystallin
form
zinc
insulin
complex
henc
zinc
concentr
pancreat
b
cell
among
highest
bodi
addit
zinc
insulin
vitro
extend
durat
insulin
action
zinc
ion
ad
vitro
produc
protamin
zinc
insulin
control
blood
sugar
diabet
patient
presenc
zinc
ion
insulin
proinsulin
dimer
aggreg
hexam
contain
bound
zinc
mrna
protein
shown
almost
exclus
confin
pancreat
islet
particip
regul
insulin
secret
believ
crucial
zinc
transport
insulin
granul
insulin
crystal
could
occur
unless
zinc
present
zinc
potent
physiolog
regul
insulin
signal
transduct
mainli
inhibitori
effect
protein
tyrosin
phosphatas
key
phosphatas
dephosphoryl
insulin
receptor
adequ
suppli
zinc
crucial
insulin
biosynthesi
storag
especi
hyperglycemia
zincdefici
state
clear
decreas
islet
cell
insulin
content
recent
studi
jansen
et
al
show
zinc
supplement
may
potenti
treatment
adjunct
type
diabet
zinc
also
promot
insulin
signal
decreas
total
bodi
zinc
diabet
patient
may
due
either
hyperzincuria
decreas
intestin
zinc
absorpt
decreas
zinc
plasma
lymphocyt
granulocyt
platelet
hyperzincuria
observ
diabet
patient
zinc
defici
contribut
diabet
complic
increas
suscept
infect
due
immun
dysfunct
increas
gener
inflammatori
cytokin
increas
oxid
stress
streptozotocininduc
diabet
rat
zinc
supplement
mgkg
zinc
sulfat
attenu
diabetesinduc
renal
oxid
damag
inflamm
prevent
kidney
diabetesinduc
proteinuria
patholog
alter
posit
correl
hyperzincuria
glycosyl
hemoglobin
observ
inflammatori
cytokin
tnfa
play
import
role
develop
complic
type
diabet
insulin
signal
interfer
adipokin
lead
insulin
resist
demonstr
serin
phosphoryl
insulin
receptor
substrat
tnfa
crp
significantli
increas
diabet
group
compar
nondiabet
control
studi
nest
casecontrol
prospect
trial
shown
tnfa
crp
elev
sever
year
onset
type
diabet
limit
trial
supplement
type
diabet
mgd
element
zinc
glucon
subject
receiv
placebo
mo
plasma
zinc
increas
significantli
c
decreas
zincsuppl
group
p
plasma
crp
show
statist
nonsignific
decreas
zinc
group
obvious
larg
placebocontrol
trial
need
firm
conclus
drawn
prospect
studi
zinc
intak
risk
type
diabet
assess
among
women
age
baselin
follow
nurs
health
studi
followup
identifi
confirm
case
incid
type
diabet
ageadjust
analysi
intak
total
zinc
dietari
zinc
food
sourc
significantli
associ
lower
risk
type
diabet
adjust
nondietari
risk
factor
includ
age
bmi
smoke
covari
highest
quintil
total
dietari
zinc
intak
significantli
associ
lower
risk
type
diabet
cellular
blood
level
zinc
increas
total
protein
phosphoryl
insulin
receptor
b
subunit
preadipocyt
adipocyt
zinc
inhibit
tyrosin
phosphatas
lead
increas
phosphoryl
insulin
receptor
b
subunit
intracellular
releas
free
zinc
potent
physiolog
regul
insulin
signal
transduct
inhibitori
effect
tyrosin
phosphatas
key
phosphatas
dephosphoryl
insulin
receptor
thu
evid
implic
import
role
zinc
diabet
manag
recommend
clinic
trial
zinc
diseas
first
descript
ad
publish
aloi
alzheim
ad
repres
preval
form
dementia
modern
societi
account
dementia
case
individu
ad
progress
cognit
declin
ultim
also
erod
higher
order
execut
function
autopsi
exhibit
number
cardin
featur
within
brain
pronounc
featur
presenc
extracellular
deposit
known
plaqu
intracellular
accumul
known
neurofibrillari
tangl
featur
diagnost
ad
gross
manifest
thin
cortic
gray
matter
enlarg
ventricular
space
gener
atrophi
brain
potenti
role
zinc
dementia
first
propos
burnet
sinc
mani
report
publish
concern
role
zinc
ad
concentr
zinc
within
brain
tend
increas
birth
adulthood
remain
stabl
throughout
life
serum
plasma
zinc
ad
patient
report
increas
unchang
decreas
thu
appear
larg
degre
variat
differ
studi
group
differ
zinc
level
frontal
lobe
tissu
brain
ad
control
howev
tissu
subfraction
signific
decreas
zinc
level
nuclear
fraction
mitochondri
microsom
fraction
ad
case
observ
decreas
zinc
level
also
seen
neocortex
superior
frontal
pariet
gyri
medial
tempor
gyru
thalamu
hippocampu
ad
patient
studi
show
senil
plaqu
core
ad
patient
consist
primarili
bamyloid
protein
ab
deriv
larger
transmembran
protein
amyloid
precursor
protein
app
zinc
copper
coordin
histidin
residu
locat
ntermin
end
protein
appear
dysregul
variou
metal
storag
transport
protein
within
ad
brain
may
contribut
failur
zinc
homeostasi
sever
key
protein
involv
regul
zinc
brain
includ
zinc
transport
zip
znt
metallothionein
furthermor
number
protein
znt
famili
found
neuropil
also
within
plaqu
app
ubiquit
express
one
function
app
particip
mainten
metal
ion
homeostasi
abnorm
express
app
might
result
dysregul
metal
ion
homeostasi
recent
report
app
possess
ironexport
ferroxidas
activ
inhibit
zinc
disturb
zinc
homeostasi
may
result
decreas
ferroxidas
activ
result
iron
accumul
process
app
gener
ab
peptid
vari
length
involv
differ
secretas
appear
interact
differ
metal
includ
zinc
gener
ab
capabl
bind
zinc
appear
metal
promot
ab
aggreg
pathway
anoth
import
consequ
bind
zinc
ab
obscur
proteolyt
cleavag
site
therebi
inhibit
abil
degrad
matrix
metalloproteinas
remov
zinc
clioquinol
howev
restor
sensit
ab
degrad
matrix
metalloproteinas
discuss
suggest
deleteri
effect
zinc
bind
app
ab
howev
sever
studi
suggest
potenti
protect
effect
zinc
certain
circumst
lovel
report
abzn
ratio
result
protect
activ
ab
toxic
effect
mediat
part
modul
na
k
atpas
activ
prevent
typic
calcium
dyshomeostasi
cell
death
associ
ab
toxic
garai
et
al
suggest
vitro
low
concentr
zinc
may
elimin
oligomer
ab
therebi
limit
toxic
mediat
solubl
oligom
suggest
zincab
aggreg
may
form
inhibit
reduct
cu
product
hydrogen
peroxid
aris
abcu
interact
repres
role
zinc
antioxid
result
displac
prooxid
cu
zinc
therapeut
modal
ad
studi
use
mice
overexpress
mutant
human
form
app
develop
cerebr
ab
plaqu
knockout
mice
suggest
zinc
may
hold
amyloid
load
dissoci
equilibrium
provid
strong
support
role
synapt
zinc
metabol
ab
studi
also
show
reduct
cerebrovascular
amyloid
load
anim
genet
ablat
may
gener
phenocopi
cognit
synapt
deficit
present
transgen
mous
model
ad
recent
number
metalmodulatori
compound
develop
normal
cerebr
zinc
ion
homeostasi
clioquinol
treatment
age
tg
mice
show
signific
reduct
plaqu
burden
parallel
shift
brain
content
ab
toward
solubl
speci
analysi
cerebr
metal
level
reveal
reduct
metal
content
show
signific
increas
copper
zinc
treatment
data
obtain
clioquinol
metalmodulatori
compound
treatment
thu
show
redistribut
metal
brain
chelat
metal
system
show
profound
effect
transgen
mous
model
ad
shown
administr
significantli
decreas
insolubl
solubl
burden
decreas
level
phosphoryl
tau
increas
level
synaptophysin
surrog
marker
synaps
rapidli
improv
learn
memori
perform
morri
water
maze
drug
current
undergo
clinic
trial
treatment
ad
patient
placebocontrol
trial
zinc
supplement
conduct
mo
recent
ad
patient
florida
subject
receiv
mgd
element
zinc
away
food
new
zinc
product
reazin
develop
adeona
pharmaceut
ann
arbor
mi
product
releas
zinc
slowli
stomach
later
small
intestin
maintain
sustain
elev
plasma
zinc
throughout
day
sum
score
cognit
measur
alzheim
diseas
assess
scalecognit
subscal
miniment
state
examin
clinic
dementia
rate
scale
assess
studi
show
zinc
stabil
cognit
wherea
placebo
group
continu
deterior
patient
age
older
studi
show
statist
signific
effect
zinc
supplement
cognit
function
recent
studi
show
neuron
stress
consequ
overexpress
proinflammatori
protein
like
instig
neuropatholog
chang
includ
plaqu
tangl
format
ad
patient
believ
microglia
cell
essenti
immun
cell
brain
shown
neuron
activ
microglia
releas
turn
activ
astrocyt
caus
releas
solubl
astrocyt
cabind
protein
proinflammatori
effect
thu
appear
associ
ad
shown
upregul
product
bapp
cord
blood
brain
thu
excess
inflammatori
cytokin
drive
forc
neurodegener
genesi
amyloid
plaqu
brain
pellet
elev
level
mrna
phosphoryl
kinas
protein
mitogenactiv
protein
kinas
shown
drive
product
tau
protein
hyperphosphoryl
via
induct
specif
kinas
mitogenactiv
protein
kinas
may
also
contribut
memori
deficit
ad
decreas
level
neurotransmitt
acetylcholin
decreas
often
seen
ad
patient
observ
enzym
acetyl
cholinesteras
degrad
acetylcholin
upregul
report
past
zinc
defici
human
cell
cultur
model
activ
macrophag
monocyt
increas
oxid
stress
via
upregul
nfkb
activ
gener
mrna
cytokin
protein
hypothes
similar
phenomenon
may
take
place
zincdefici
elderli
subject
microglia
cell
oxid
stress
due
zinc
defici
lead
upregul
brain
cell
increas
turn
could
upregul
gener
ab
tau
protein
hyperphosphoryl
tau
protein
lead
format
neurofibril
damag
neuron
cell
hypothesi
correct
one
would
see
effect
prevent
ad
zincdefici
elderli
patient
supplement
zinc
mgd
element
zinc
correct
defici
hypothesi
need
test
correct
zinc
supplement
may
prove
import
therapeut
adjunct
ad
